Atlas Trials

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

Clinical trial NCT01508468 · COMPLETED

Trial details

NCT number
NCT01508468
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Membranous Nephropathy
Start date
2012-01-17
Primary completion
2016-08-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.